Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Cleveland Clinic
mi
from
Cleveland, OH
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
OHSU Casey Eye Institute
mi
from
Portland, OR
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
OHSU Casey Eye Institute
mi
from
Portland, OR
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Charleston Neuroscience Institute
mi
from
Ladson, SC
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Charleston Neuroscience Institute
mi
from
Ladson, SC
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Texas Retina Associates
mi
from
Arlington, TX
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Texas Retina Associates
mi
from
Arlington, TX
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Retina Consultants of Houston
mi
from
Houston, TX
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Foresight Studies, LLC
mi
from
San Antonio, TX
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Foresight Studies, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Northwestern University
mi
from
Chicago, IL
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Augenarzte am St. Franziskus Hospital
mi
from
Munster,
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Augenarzte am St. Franziskus Hospital
mi
from
Munster,
Click here to add this to my saved trials
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase III, Multi-National, Multi-Center, Randomized, Masked, Controlled, Safety and Efficacy Study of a Fluocinolone Acetonide Intravitreal Insert in Subjects With Chronic Non-Infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Retinal Consultants Medical Group, Inc.
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Retina Consultants of Southern Colorado
mi
from
Colorado Springs, CO
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Retina Consultants of Southern Colorado
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Ocular Immunology and Uveitis Foundation
mi
from
Waltham, MA
Click here to add this to my saved trials
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Charleston Neuroscience Center
mi
from
Ladson, SC
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Charleston Neuroscience Center
mi
from
Ladson, SC
Click here to add this to my saved trials
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated:  4/2/2018
Texas Retina Associates - Fort Worth
mi
from
Arlington, TX
A Controlled, Multi-center Study of the Utilization and Safety of the MK II Inserter and the Safety of the FAI Insert in Subjects With Non-infectious Uveitis Affecting the Posterior Segment of the Eye
Status: Enrolling
Updated: 4/2/2018
Texas Retina Associates - Fort Worth
mi
from
Arlington, TX
Click here to add this to my saved trials
Glaucoma Eye Drop Instillation: Impact of Education
Glaucoma Eye Drop Instillation: Impact of Education
Status: Enrolling
Updated:  4/3/2018
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Glaucoma Eye Drop Instillation: Impact of Education
Glaucoma Eye Drop Instillation: Impact of Education
Status: Enrolling
Updated: 4/3/2018
Northwestern Medical Faculty Foundation
mi
from
Chicago, IL
Click here to add this to my saved trials
Neovascular Age-related Macular Degeneration
OCT Evaluation of Treated and Untreated Choroidal Neovascular Membranes in Age-Related Macular Degeneration
Status: Enrolling
Updated:  4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Neovascular Age-related Macular Degeneration
OCT Evaluation of Treated and Untreated Choroidal Neovascular Membranes in Age-Related Macular Degeneration
Status: Enrolling
Updated: 4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Non-exudative Age-related Macular Degeneration
A Prospective Study Examining Patients With Non-exudative Age-related Macular Degeneration (NEAMD) of Different Severity
Status: Enrolling
Updated:  4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Non-exudative Age-related Macular Degeneration
A Prospective Study Examining Patients With Non-exudative Age-related Macular Degeneration (NEAMD) of Different Severity
Status: Enrolling
Updated: 4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
A Prospective,Randomized,Masked,Study to Evaluate the Interaction of Non-Steroidal Anti-Inflammatory Agent With IOP-Lowering Effect of Brimonidine or Latanoprost.
Status: Enrolling
Updated:  4/3/2018
Philadelphia Eye Associates
mi
from
Willingboro, NJ
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
A Prospective,Randomized,Masked,Study to Evaluate the Interaction of Non-Steroidal Anti-Inflammatory Agent With IOP-Lowering Effect of Brimonidine or Latanoprost.
Status: Enrolling
Updated: 4/3/2018
Philadelphia Eye Associates
mi
from
Willingboro, NJ
Click here to add this to my saved trials
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
A Prospective,Randomized,Masked,Study to Evaluate the Interaction of Non-Steroidal Anti-Inflammatory Agent With IOP-Lowering Effect of Brimonidine or Latanoprost.
Status: Enrolling
Updated:  4/3/2018
Philadelphia Eye Associates
mi
from
Philadelphia, PA
Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops
A Prospective,Randomized,Masked,Study to Evaluate the Interaction of Non-Steroidal Anti-Inflammatory Agent With IOP-Lowering Effect of Brimonidine or Latanoprost.
Status: Enrolling
Updated: 4/3/2018
Philadelphia Eye Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts
Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts
Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts
Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts
Status: Enrolling
Updated:  4/4/2018
Zhongshan Ophthalmic Center
mi
from
Guangzhou,
Clinical and Genetic Studies of Families With Congenital or Hereditary Cataracts
Clinical and Molecular Studies in Families With Congenital or Hereditary Cataracts
Status: Enrolling
Updated: 4/4/2018
Zhongshan Ophthalmic Center
mi
from
Guangzhou,
Click here to add this to my saved trials
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated:  4/4/2018
Harvard Medical School
mi
from
Boston, MA
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated: 4/4/2018
Harvard Medical School
mi
from
Boston, MA
Click here to add this to my saved trials
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated:  4/4/2018
Cleveland Clinic Foundation Childrens Hospital
mi
from
Cleveland, OH
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated: 4/4/2018
Cleveland Clinic Foundation Childrens Hospital
mi
from
Cleveland, OH
Click here to add this to my saved trials
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated:  4/4/2018
Sun Yat-Sen University
mi
from
Guangzhou,
Molecular Genetics of Retinal Degenerations
Molecular Genetics of Retinal Degenerations
Status: Enrolling
Updated: 4/4/2018
Sun Yat-Sen University
mi
from
Guangzhou,
Click here to add this to my saved trials
AMD Phenotype and Genotype Study
AMD Phenotype and Genotype Study (APGS)
Status: Enrolling
Updated:  4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
AMD Phenotype and Genotype Study
AMD Phenotype and Genotype Study (APGS)
Status: Enrolling
Updated: 4/4/2018
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
AMD Phenotype and Genotype Study
AMD Phenotype and Genotype Study (APGS)
Status: Enrolling
Updated:  4/4/2018
University of Bonn
mi
from
Bonn,
AMD Phenotype and Genotype Study
AMD Phenotype and Genotype Study (APGS)
Status: Enrolling
Updated: 4/4/2018
University of Bonn
mi
from
Bonn,
Click here to add this to my saved trials
Pilot Study of OCT Versus Fluorescein Angiography in DME
Pilot Study of OCT Versus Fluorescein Angiography in Diabetic Macular Edema in Eyes With Good and Poor Macular Capillary Perfusion
Status: Enrolling
Updated:  4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
Pilot Study of OCT Versus Fluorescein Angiography in DME
Pilot Study of OCT Versus Fluorescein Angiography in Diabetic Macular Edema in Eyes With Good and Poor Macular Capillary Perfusion
Status: Enrolling
Updated: 4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Corneal Power, Astigmatism, and Aberration Changes After LASIK
Observational Study of Corneal Power, Astigmatism, and Aberration Changes After LASIK
Status: Enrolling
Updated:  4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
Corneal Power, Astigmatism, and Aberration Changes After LASIK
Observational Study of Corneal Power, Astigmatism, and Aberration Changes After LASIK
Status: Enrolling
Updated: 4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Status: Enrolling
Updated:  4/4/2018
Contact Paul Rhee at Ivantis
mi
from
Irvine, CA
Comparing Hydrus Microstent(TM) to the iStent for Lowering IOP in Glaucoma Patients Undergoing Cataract Surgery
A Prospective, Multicenter, Randomized Comparison of the Hydrus Microstent to the iStent for Lowering Intraocular Pressure in Glaucoma Patients Undergoing Cataract Surgery
Status: Enrolling
Updated: 4/4/2018
Contact Paul Rhee at Ivantis
mi
from
Irvine, CA
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Retina-Vitreous Assoc Med Grp
mi
from
Beverly Hills, CA
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Retina-Vitreous Assoc Med Grp
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Dr. Andrew Gardner Logan, FL
mi
from
Tamarac, FL
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Dr. Andrew Gardner Logan, FL
mi
from
Tamarac, FL
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Perez & Perez, MDs PA
mi
from
Tampa, FL
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Perez & Perez, MDs PA
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Emory University Hospital
mi
from
Atlanta, GA
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Northwestern University
mi
from
Chicago, IL
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Rush University Medical Center
mi
from
Chicago, IL
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Ellsworth Uveitis & Retina Car
mi
from
Ellsworth, ME
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Ellsworth Uveitis & Retina Car
mi
from
Ellsworth, ME
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Kresge Eye Institute
mi
from
Detroit, MI
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Kresge Eye Institute
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Metro Eye Res and Surgery Inst
mi
from
Palisades Park, NJ
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Metro Eye Res and Surgery Inst
mi
from
Palisades Park, NJ
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
New York Eye & Ear Infirmary
mi
from
New York, NY
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
New York Eye & Ear Infirmary
mi
from
New York, NY
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Duke Univ Med Ctr
mi
from
Durham, NC
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Wake Forest Univ HS
mi
from
Winston-Salem, NC
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Wake Forest Univ HS
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Dean McGee Eye Institute
mi
from
Oklahoma City, OK
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Dean McGee Eye Institute
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Texas Retina Associates
mi
from
Dallas, TX
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Texas Retina Associates
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Houston Eye Associates
mi
from
Houston, TX
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Houston Eye Associates
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Retina Consultants of Houston
mi
from
Houston, TX
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Retina Consultants of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Valley Retina Institute, P.A.
mi
from
McAllen, TX
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Valley Retina Institute, P.A.
mi
from
McAllen, TX
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Foresight Studies, LLC
mi
from
San Antonio, TX
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Foresight Studies, LLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
University of Utah
mi
from
Salt Lake City, UT
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated:  4/4/2018
Virginia Eye Consultants
mi
from
Norfolk, VA
A Study of the Long-term Safety and Efficacy of Adalimumab in Subjects With Intermediate-, Posterior-, or Pan-uveitis
A Multicenter Open-Label Study of the Long-term Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Non-infectious Intermediate-, Posterior-, or Pan-uveitis
Status: Enrolling
Updated: 4/4/2018
Virginia Eye Consultants
mi
from
Norfolk, VA
Click here to add this to my saved trials